CClinicalTrials.gg
CompletedNCT00371839Updated Dec 8, 2014Results posted

Clinical Applications for Time-Compressed Speech Tests

An interventional study of Audiological Evaluation in Hearing Loss, sponsored by US Department of Veterans Affairs. Completed. Open to participants aged 50 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-12-08.

Sponsored by US Department of Veterans Affairs · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Non-randomized
Ages
50 Years to 75 Years
Sex
All
01

Study summary

The purpose of this study is to determine the effects of age-related cognitive changes on hearing aid benefit based on hearing aid compression time constants.

The hypothesis is that people with poor working memory skills will benefit from slow time constants in hearing aid compression while those with good working memory skills will be able to benefit from more sophisticated compression algorithms with rapid time constants.

Read the detailed description

Recent research has shown the relevance of cognitive function in hearing aid evaluation and the sensitivity of the aging auditory system to temporal distortions. The proposed investigation will examine the interaction of working memory and hearing aid compression method on speech recognition in background competition for older listeners. This interaction will be investigated for the following three forms of background competition:

  1. Competition from continuous speech-shaped noise.
  2. Competition from speech-modulated noise.
  3. Competition from a single interfering talker.

The goals of the study will be accomplished in two phases. In the first phase, 160 adults aged 50 through 75 years will be evaluated on a battery of tests to determine their cognitive capacity, time-compressed speech scores and their candidacy for inclusion in the second phase of the study. At the conclusion of this phase of testing, the participants will be divided into three groups:

  1. subjects with TCS test scores in the highest quartile (the HIGH group)
  2. subjects with TCS test scores in the lowest quartile (the LOW group)
  3. the remaining listeners

The second phase of the experiment will include listeners from the HIGH and LOW groups only. These subjects will be evaluated with respect to their speech recognition ability for three types of interference (steady-state noise, speech-modulated noise, single interfering talker). The HINT test (Nilsson, Soli, \& Sumida, 1995; Nilsson et al., 1994) will be used to obtain the signal-to-noise ratio (SNR) at 50% recognition for the three masking conditions for each of three types of amplification:

  1. one- channel linear amplification (LINEAR) with frequency shaping
  2. two-channel wide dynamic range compression with fast time constants (FAST)
  3. two-channel wide dynamic range compression with slow time constants (SLOW) Listener groups will be compared across hearing aid conditions and across background interference conditions.
02

Conditions studied

  • Hearing Loss

Keywords

  • Hearing Loss
  • Hearing Aids
  • Rehabilitation of hearing impaired
03

In context

Hearing Loss

1,092 studies on the registry are indexed under Hearing Loss; 235 are open to participants now.

This study's enrollment of 78 is above the median of 40 across 764 interventional studies indexed under Hearing Loss.

Browse Hearing Loss studies →

Lead sponsor

US Department of Veterans Affairs is the lead sponsor of 658 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants will be 50 to 75 years old.
  • Hearing loss will be limited to 40 dB HL from 250 Hz through 1000 Hz, and to 60 dB HL through 4000 Hz.
  • Hearing loss must be greater than 25 dB at two or more frequencies from 250 to 4000 Hz.

Exclusion criteria

Exclusion Criteria:

  • None of the participants will be current or past hearing aid users; all will be free of ear disease.
  • Participants with conductive hearing losses, defined as air-bone gap greater than 15 dB, will be excluded.
  • The audiometric battery with acoustic reflex thresholds and decay measurements will be used to exclude anyone with evidence of a central disorder or a pathology other than a sensorineural loss. Those potential participants will be referred to a medical professional.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
78 participants (actual)

Study arms

  • Active comparator
    Mild Hearing Loss

    Audiological Evaluation will show average hearing threshold at 500, 1000, 2000, and 4000 Hz of 20-39 decibels hearing level (dBHL)

    Procedure: Audiological Evaluation

  • Active comparator
    Moderate Hearing Loss

    Audiological Evaluation will show average hearing threshold at 500, 1000, 2000, and 4000 Hz of 40-49 decibels hearing level (dBHL)

    Procedure: Audiological Evaluation

  • Active comparator
    Moderate-Severe Hearing Loss

    Audiological Evaluation will show average hearing threshold at 500, 1000, 2000, and 4000 Hz greater than 50 decibels hearing level (dBHL)

    Procedure: Audiological Evaluation

Interventions

  • ProcedureAudiological Evaluation

    Tests of hearing, cognition, and speech perception

06

What researchers measure

Primary outcomes

  1. Ability to Understand Speech in Noise Background

    Measure speech perception for sentences in background noise

    Time frame: one year

07

Results

Posted Nov 19, 2014

Participant flow

Veterans from 50 to 75 years of age with hearing loss, not hearing aid wearers

Participant flow — Overall Study
MilestoneMild HLMod HLModSev HL
Started49209
Completed32137
Not completed1772
Withdrew: Death400
Withdrew: Withdrawal by subject740
Withdrew: Lost to follow-up632

Outcome measures

PrimaryAbility to Understand Speech in Noise Background

Measure speech perception for sentences in background noise

Time frame:
one year
Reported as:
Mean · Percent correct of 100 presented words
Ability to Understand Speech in Noise Background
Percent correct of 100 presented wordsMild HLMod HLModSev HL
Ability to Understand Speech in Noise Background84 ± 4.078 ± 7.047 ± 9.0

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Arm 1—6/69 (8.7%)—
Most frequent serious events
Most frequent serious events
EventArm 1
Death or terminal illnessGeneral disorders6/69

Baseline characteristics

Number of participants who completed the study

Age, Continuous
Age, Continuous(years)Mild HLMod HLModSev HLTotal
Mean59.9 ± 6.862.7 ± 7.065.1 ± 5.161.7 ± 5.1
Sex: Female, Male
Sex: Female, Male(Participants)Mild HLMod HLModSev HLTotal
Female1113
Male3112649
08

Study locations

No study locations are listed for this record.

09

References and documents

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 8, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00371839
Lead sponsor
US Department of Veterans Affairs
Responsible party
Sponsor
First posted
Sep 4, 2006
Start date
Sep 2006
Primary completion
Dec 2010
Completion
Dec 2011
Results posted
Nov 19, 2014
Last update
Dec 8, 2014

Study contacts

Marjorie R. Leek, PhD
principal investigator · VA Loma Linda Healthcare System, Loma Linda, CA

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion